Northwest Biotherapeutics reported 31.58M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Agenus USD 58.98M 12.1M Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Celldex Therapeutics USD 14.68M 4.32M Jun/2026
Eisai JPY 87.53B 11.64B Jun/2026
Merck USD 3.83B 36M Jun/2026
Northwest Biotherapeutics 31.58M 5.13M Mar/2026
Pfizer USD 4.58B 75M Jun/2026
Plus Therapeutics 6.16M 237K Mar/2026
Roche Holding CHF 5.54B 237M Jun/2026